Try it
Biochemistry · Pyrimidine synthesis: leflunomide
Sample itemA woman with rheumatoid arthritis takes leflunomide. Its active metabolite, teriflunomide, preferentially suppresses activated lymphocytes because it inhibits which enzyme?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Dihydroorotate dehydrogenase, a step in de novo pyrimidine synthesis
Dihydroorotate dehydrogenase, located on the inner mitochondrial membrane, oxidises dihydroorotate to orotate. Activated lymphocytes depend heavily on de novo pyrimidine synthesis because their salvage capacity is limited, so inhibition arrests their proliferation; uridine can partially rescue cells. Hepatotoxicity and teratogenicity are important adverse effects.
Option by option
A. Dihydroorotate dehydrogenase, a step in de novo pyrimidine synthesis (correct)
Blocking dihydroorotate dehydrogenase starves proliferating lymphocytes of pyrimidines.
B. Dihydrofolate reductase
Dihydrofolate reductase is inhibited by methotrexate, which is a different disease-modifying drug.
C. Xanthine oxidase
Xanthine oxidase is inhibited by allopurinol and febuxostat in gout.
D. IMP dehydrogenase in de novo purine synthesis
IMP dehydrogenase inhibition is the mechanism of mycophenolate and affects guanine nucleotides.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Biochemistry questions
- Nucleotide metabolismA 4-year-old boy has intellectual disability, dystonia, self-mutilation and hyperuricaem…
- VitaminsA patient with megaloblastic anaemia and mild neurological signs has raised serum methyl…
- Amino acid metabolismA baby has a mousy odour, fair skin and developmental delay. Which enzyme is deficient?
- Glycogen storage diseasesA child has severe fasting hypoglycaemia, hepatomegaly, lactic acidosis and hyperuricaem…